A MELBOURNE research trial has paved the way for improved outcomes for stroke patients.
Clot busting drug tenecteplase administered prior to clot retrieval meant some patients were able to avoid surgery and restore blood flow - ncbi.nlm.nih.gov.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Apr 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Apr 18